Furthermore, increased insulin-like growth factor receptor (IGF-1R) protein levels and an activation of the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3 beta/β-catenin signaling pathway were identified in a mouse neurodegenerative disease model (55). This evidence concerns the gene IGF1R and neurodegenerative disease.